U.S. Food and Drug Administration Approves First Treatment for Group of Progressive Interstitial Lung Diseases | site (https://forum.ltgof.net/articles/med...-lung-diseases) | (March 9, 2020) - - Today, the U.S. Food and Drug Administration (FDA) published the following information: The U.S. Food and Drug Administration today approved Ofev (nintedanib) oral capsules to treat patients with chronic fibrosing...

More...